HNN3.0
Register
Register
Register

Project cooperationUpdated on 30 December 2025

European Projects Partnership

Business Development at 3ahealth

Nicosia, Cyprus

About

3ahealth is a digital health SME specialized in the design and development of interoperable clinical information systems, AI-powered clinical decision support tools, and citizen-centered digital health services. R&D&I is deeply embedded in our company’s identity—our team includes five PhD holders and long-standing experience in European and national collaborative projects. Our mission is to translate research outcomes into real-world, plug-and-play Alasia Health modules serving hospitals, clinics, and citizens.

We are actively seeking partners for Horizon Europe consortia, with strong expertise in:

  • AI for hospital transformation, clinical decision support, risk prediction, and workflow optimization

  • Real-time physiological data processing, digital biomarkers, and wearable integration

  • Interoperability & EHDS implementation, cross-border data exchange, IPS/FHIR/IHE frameworks

  • Digital therapeutics & remote monitoring pipelines

  • Clinical workflow automation in ICU, ED, oncology, and long-term care

Representative Projects:

  • HOSPAITAL – Hospital Transformation through AI: Developed state-of-the-art AI models for ICU and ED, including early sepsis prediction (now piloted in Nicosia General ICU with real-time hospital data), ICU/ED admission probability, LOS prediction, and mortality prediction. (https://hospitalai.eu)

  • PROTECT – AI-assisted brachytherapy planning: 3ahealth leads real-time segmentation of the prostate region and intra-operative imaging workflows, integrated into the Alasia Health EHR. (https://protect-prostate.eu)

  • VELES – Excellence Hub for Smart Health: Strengthening regional collaboration and early EHDS adoption. 3ahealth contributes cross-border health data interoperability and leads Cyprus’ dementia pilot, correlating stress and pain responses in VR scenarios with physiological signals from wearables. (https://veleshub.eu)

  • Additional R&D involvement includes projects in precision medicine, oncology AI, postpartum health, and health system digitisation.

We welcome collaboration with hospitals, universities, research institutes, SMEs, medtech companies, and industry partners to build competitive, high-impact proposals for Horizon Europe and related programmes.

Organisation

3ahealth

Company (SME)

Nicosia, Cyprus

Similar opportunities

  • Project cooperation

    Alasia Health

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Evangelia Athanasiou

    Business Development at 3ahealth

    Nicosia, Cyprus

  • Project cooperation

    AI-Driven Digital Health Platform for Predictive, Preventive, and Personalised Care

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    Ioannis Gkouzionis

    CEO at Aisthesis Medical

    London, United Kingdom

  • Project cooperation

    Project Cooperation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Ilona Ruotsalainen

    Senior Scientist at Technical Research Centre of Finland VTT Ltd

    Kuopio, Finland